June 15, 2022 NIAID Funding News Read this full edition online at http://www.niaid.nih.gov/grants-contracts/funding-news-notices Feature Articles The exploratory/developmental grant (R21) activity code provides up to two years of funding support. Typically, direct costs for the entire project period are capped at $275,000. Opportunities and Resources Conduct clinical history studies to consider the full spectrum of infection, from infection to screening and the interval after screening from treatment through follow-up exams. Generate omics data from clinical or experimental samples, leverage computational approaches to generate hypotheses from omics data, and test the hypotheses in experimental settings. Apply to conduct research on biological and immunological factors that contribute to HIV and sexually transmitted infections in transgender people. Investigators may submit short applications to request and justify access to a discrete set of preclinical services provided by NIAID contractors at no cost to the applicants. Identify, develop, or test strategies to overcome barriers to dissemination and implementation of evidence-based interventions into public health, clinical practice, and community settings. In The News We've set final paylines for research project grants, fellowship awards, career development awards, and small business grants for fiscal year (FY) 2022. Help improve NIH's understanding of potential research funding, priority setting, administrative practices, and strategies that could encourage or facilitate equitable global health research. Provide feedback on how researchers should consider whether to control access to scientific data from participants, even if de-identified and lacking explicit limitations on subsequent use. An NIH program officer may nominate your R01 application for R56-Bridge award consideration based on the innovation, merit, and programmatic importance of your proposed research. The prize competition will acknowledge and reward transformative interventions developed by institutions to create research environments that promote and value diversity, equity, inclusion, and accessibility (DEIA). Provide information to help the National Science and Technology Council improve inclusive and equitable access to federal programs and resources. Advice Corner Institutions should possess values and behaviors that emphasize safety in both the laboratory and clinical setting, and those who are working in labs must take safety seriously and take precautions to protect themselves. Reader Questions New Funding Opportunities - RFA-NS-22-051, Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C, Clinical Trial Not Allowed)
- RFA-ES-22-003, Research Coordinating Center To Support Climate Change and Health Community of Practice (U24, Clinical Trial Not Allowed)
- NOT-ES-22-009, Notice of Special Interest (NOSI)—Innovative Technologies for Research on Climate Change and Human Health Small Business Technology Transfer (R41/R42, Clinical Trial Optional)
- NOT-ES-22-010, Notice of Special Interest (NOSI)—Innovative Technologies for Research on Climate Change and Human Health Small Business Innovation Research (R43/R44, Clinical Trial Optional)
- PA-22-176, PHS 2022-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44], Clinical Trial Not Allowed)
- PA-22-178, PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42], Clinical Trial Not Allowed)
Find other announcements at NIAID Opportunities & Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. |
Belum ada tanggapan untuk "NIAID Funding News, June 15, 2022"
Post a Comment